In patients with established MDS, BM histology and IHC provide important diagnostic information and/or may reveal prognostic features, including BM fibrosis, a focal increase in CD34+ progenitors, increased angiogenesis, a hypocellular BM or concomitant mastocytosis (Table 4) [23-25]. Here, CD34 is linked to myelodysplastic syndrome.